Search

Your search keyword '"Belzeaux, R."' showing total 452 results
Start Over Author "Belzeaux, R."
452 results on '"Belzeaux, R."'

2. Diet quality and associations with lactate and metabolic syndrome in bipolar disorder

Author

Etain, B., Olié, E., Leboyer, M., Haffen, E., Llorca, P.M., Barteau, V., Bensalem, S., Godin, O., Laouamri, H., Souryis, K., Hotier, S., Pelletier, A., Hergeta, F., Petrucci, J., Willaume, L., Bellivier, F., Hennion, V., Marlinge, E., Meheust, J., Richard, A., Carminati, M., Francisque, H., Dubertret, C., Mazer, N., Portalier, C., Scognamiglio, C., Bing, A., Laurent, P., Gard, S., M'Bailara, K., Elkael, C., Hoorelbeke, F., Minois, I., Sportich, J., Da Ros, N., Boukhobza, L., Courtet, P., Denat, S., Deffinis, B., Ducasse, D., Gachet, M., Lengvenyté, A., Molière, F., Nass, L., Tarquini, G., Lefrere, A., Moreau, E., Pastol, J., Groppi, F., Polomeni, H., Bauberg, J., Lescalier, L., Muraccioli, I., Suray, A., Cohen, R., Kahn, J.P., Milazzo, M., Wajsbrot-Elgrabli, O., Bougerol, T., Pouchon, A., Bertrand, A., Fredembach, B., Suisse, A., Denoual, Q., Polosan, M., Galliot, A.M., Brehon, L., Bonny, G., Durand, L., Feuga, V., Kayser, N., Roux, P., Aubin, V., Cussac, I., Dupont, M.A., Loftus, J., Medecin, I., Samalin, L., Mennetrier, M., Bonnet, T., Lacelle, D., Vayssié, M., Beal, C., Blanc, O., Zachos, Kassandra A., Godin, Ophelia, Choi, Jaehyoung, Jung, Jae H., Aouizerate, Bruno, Aubin, Valérie, Bellivier, Frank, Belzeaux-R, Raoul, Courtet, Philippe, Dubertret, Caroline, Etain, Bruno, Haffen, Emmanuel, Lefrere A, Antoine, Llorca, Pierre-Michel, Olié, Emilie, Polosan, Mircea, Samalin, Ludovic, Schwan, Raymund, Roux, Paul, Barau, Caroline, Richard, Jean Romain, Tamouza, Ryad, Leboyer, Marion, and Andreazza, Ana C.

Published
2024
Full Text
View/download PDF

3. Mitochondrial Biomarkers and Metabolic Syndrome in Bipolar Disorder

Author

Etain, B., Olié, E., Leboyer, M., Haffen, E., Llorca, PM, Barteau, V., Bensalem, S., Godin, O., Laouamri, H., Souryis, K., Hotier, S., Pelletier, A., Hergeta, F., Petrucci, J., Willaume, L., Bellivier, F., Hennion, V., Marlinge, E., Meheust, J., Richard, A., Carminati, M., Francisque, H., Dubertret, C., Mazer, N., Portalier, C., Scognamiglio, C., Bing, A., Laurent, P., Gard, S., M'Bailara, K., Elkael, C., Hoorelbeke, F., Minois, I., Sportich, J., Da Ros, N., Boukhobza, L., Courtet, P., Denat, S., Deffinis, B., Ducasse, D., Gachet, M., Lengvenyté, A., Molière, F., Nass, L., Tarquini, G., Lefrere, A., Moreau, E., Pastol, J., Groppi, F., Polomeni, H., Bauberg, J, Lescalier, L., Muraccioli, I., Suray, A., Cohen, R., Kahn, J.P., Milazzo, M., Wajsbrot-Elgrabli, O., Bougerol, T., Pouchon, A., Bertrand, A, Fredembach, B., Suisse, A., Denoual, Q, Polosan, M, Galliot, A.M., Brehon, L., Bonny, G, Durand, L, Feuga, V, Kayser, N., Roux, P., Aubin, V., Cussac, I., Dupont, M.A, Loftus, J., Medecin, I., Samalin, L., Llorca, PM., Mennetrier, M., Bonnet, T., Lacelle, D., Vayssié, M., Beal, C., Blanc, O., Zachos, Kassandra A., Choi, Jaehyoung, Godin, Ophelia, Chernega, Timofei, Kwak, Haejin Angela, Jung, Jae H., Aouizerate, Bruno, Aubin, Valérie, Bellivier, Frank, Belzeaux-R, Raoul, Courtet, Philippe, Dubertret, Caroline, Etain, Bruno, Haffen, Emmanuel, Lefrere A, Antoine, Llorca, Pierre-Michel, Olié, Emilie, Polosan, Mircea, Samalin, Ludovic, Schwan, Raymund, Roux, Paul, Barau, Caroline, Richard, Jean Romain, Tamouza, Ryad, Leboyer, Marion, and Andreazza, Ana C.

Published
2024
Full Text
View/download PDF

4. Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort

Author

Etain, B., Olié, E., Leboyer, M., Haffen, E., Llorca, P.M., Barteau, V., Bensalem, S., Godin, O., Laouamri, H., Souryis, K., Hotier, S., Pelletier, A., Drancourt, N., Sanchez, J.P., Saliou, E., Hebbache, C., Petrucci, J., Willaume, L., Bourdin, E., Bellivier, F., Carminati, M., Marlinge, E., Meheust, J., Hennion, V., Francisque, H., Aouizerate, B., Da Ros, N., Desage, A., Elkael, C., Gard, S., Hoorelbeke, F., M'bailara, K., Minois, I., Sportich, J., Boukhobza, L., Benramdane, M., Courtet, P., Deffinis, B., Denat, S., Ducasse, D., Gachet, M., Molière, F., Nass, L., Tarquini, G., Belzeaux, R., Cermolacce, M., Groppi, F., Moreau, E., Lefrere, A., Lescalier, L., Pastol, J., Viglianese, N., Cohen, R., Gross, G., Schwan, R., Schwitzer, T., Wajsbrot-Elgrabli, O., Bougerol, T., Fredembach, B., Denoual, Q, Bertrand, A., Pouchon, A., Polosan, M., Bonny, G., Brehon, L., Durand, L., Feuga, V., Galliot, A.M., Kayser, N., Passerieux, C., Roux, P., Aubin, V., Cussac, I., Dupont, M.A., Loftus, J., Medecin, I., Dubertret, C., Mazer, N., Portalier, C., Scognamiglio, C., Bing, A., Laurent, P., Llorca, PM., Samalin, L., Foures, L., Lacelle, D., Pires, S., Doriat, C., Blanc, O., Bennabi, D., Nicolier, M., Vidal, N., Brunet-Gouet, E., Frileux, S., D'Amato, T., Januel, D., and Walter, M.

Published
2023
Full Text
View/download PDF

7. Clinical characteristics of bipolar disorders with postpartum depressive onset

Author

Etain, B., Henry, C., Olié, E., Leboyer, M., Haffen, E., Llorca, P.M., Barteau, V., Bensalem, S., Godin, O., Laouamri, H., Souryis, K., Hotier, S., Pelletier, A., Drancourt, N., Sanchez, J.P., Saliou, E., Hebbache, C., Petrucci, J., Willaume, L., Bourdin, E., Bellivier, F., Carminati, M., Marlinge, E., Meheust, J., Antoniol, B., Desage, A., Gard, S., Jutant, A., Mbailara, K., Minois, I., Zanouy, L., Abettan, C., Bardin, L., Cazals, A., Courtet, P., Deffinis, B., Ducasse, D., Gachet, M., Henrion, A., Martinerie, E., Molière, F., Noisette, B., Tarquini, G., Azorin, J.M., Belzeaux, R., Correard, N., Consoloni, J.L., Groppi, F., Lescalier, L., Montant, J., Rebattu, M., Viglianese, N., Cohen, R., Kahn, J.P., Milazzo, M., Wajsbrot-Elgrabli, O., Bougerol, T., Fredembach, B., Suisse, A., Halili, B., Pouchon, A., Polosan, M., Galliot, A.M., Grévin, I., Cannavo, A.S., Kayser, N., Passerieux, C., Roux, P., Aubin, V., Cussac, I., Dupont, M.A., Loftus, J., Medecin, I., Dubertret, C., Mazer, N., Portalier, C., Scognamiglio, C., Bing, A., Tebeka, Sarah, Godin, Ophelia, Mazer, Nicolas, Bellivier, Frank, Courtet, Philippe, Etain, Bruno, Gard, Sébastien, Leboyer, Marion, Llorca, Pierre-Michel, Loftus, Joséphine, Olié, Emilie, Passerieux, Christine, Polosan, Mircea, Schwan, Raymund, Belzeaux, Raoul, and Dubertret, Caroline

Published
2021
Full Text
View/download PDF

8. Clinical predictors of recurrences in bipolar disorders type 1 and 2: A FACE-BD longitudinal study

Author

Etain, B., Olié, E., Leboyer, M., Llorca, P.M., Henry, C., Barteau, V., Bensalem, S., Godin, O., Laouamri, H., Souryis, K., Hotier, S., Pelletier, A., Sanchez, J.P., Saliou, E., Hebbache, C., Petrucci, J., Willaume, L., Bourdin, E., Bellivier, F., Carminati, M., Maruani, J., Marlinge, E., Meheust, J., Antoniol, B., Desage, A., Gard, S., Jutant, A., Mbailara, K., Minois, I., Zanouy, L., Abettan, C., Bardin, L., Cazals, A., Courtet, P., Deffinis, B., Ducasse, D., Gachet, M., Henrion, A., Martinerie, E., Molière, F., Noisette, B., Tarquini, G., Azorin, J.M., Belzeaux, R., Correard, N., Consoloni, J.L., Groppi, F., Lescalier, L., Montant, J., Rebattu, M., Viglianese, N., Cohen, R., Gross, G., Schwan, R., Schwitzer, T., Wajsbrot-Elgrabli, O., Bougerol, T., Fredembach, B., Suisse, A., Halili, B., Gaoua, Z., Polosan, M., Cannavo, A.S., Galliot, A.M., Grévin, I., Kayser, N., Liaskovski, G., Passerieux, C., Roux, P., Aubin, V., Cussac, I., Dupont, M.A., Loftus, J., Medecin, I., Dubertret, C., Mazer, N., Portalier, C., Scognamiglio, C., Bing, A., and Aouizerate, B.

Published
2021
Full Text
View/download PDF

9. Evolution and characteristics of the use of valproate in women of childbearing age with bipolar disorder: Results from the FACE-BD cohort

Author

Samalin, L., Godin, O., Olié, E., Etain, B., Henry, C., Pelletier, A., Poinso, F., Encely, L., Mazer, N., Roux, P., Loftus, J, Gard, S., Bennabi, D., Polosan, M., Schwitzer, T., Aubin, V., Schwan, R., Passerieux, C., Bougerol, T., Dubertret, C., Aouizerate, B., Haffen, E., Courtet, P., Bellivier, F., Leboyer, M., Llorca, P.M., and Belzeaux, R.

Published
2020
Full Text
View/download PDF

10. Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort

Author

Vidal, N., primary, Brunet-Gouet, E., additional, Frileux, S., additional, Aouizerate, B., additional, Aubin, V., additional, Belzeaux, R., additional, Courtet, P., additional, D'Amato, T., additional, Dubertret, C., additional, Etain, B., additional, Haffen, E., additional, Januel, D., additional, Leboyer, M., additional, Lefrere, A., additional, Llorca, P.M., additional, Marlinge, E., additional, Olié, E., additional, Polosan, M., additional, Schwan, R., additional, Walter, M., additional, Passerieux, C., additional, Roux, P., additional, Barteau, V., additional, Bensalem, S., additional, Godin, O., additional, Laouamri, H., additional, Souryis, K., additional, Hotier, S., additional, Pelletier, A., additional, Drancourt, N., additional, Sanchez, J.P., additional, Saliou, E., additional, Hebbache, C., additional, Petrucci, J., additional, Willaume, L., additional, Bourdin, E., additional, Bellivier, F., additional, Carminati, M., additional, Meheust, J., additional, Hennion, V., additional, Francisque, H., additional, Da Ros, N., additional, Desage, A., additional, Elkael, C., additional, Gard, S., additional, Hoorelbeke, F., additional, M'bailara, K., additional, Minois, I., additional, Sportich, J., additional, Boukhobza, L., additional, Benramdane, M., additional, Deffinis, B., additional, Denat, S., additional, Ducasse, D., additional, Gachet, M., additional, Molière, F., additional, Nass, L., additional, Tarquini, G., additional, Cermolacce, M., additional, Groppi, F., additional, Moreau, E., additional, Lescalier, L., additional, Pastol, J., additional, Viglianese, N., additional, Cohen, R., additional, Gross, G., additional, Schwitzer, T., additional, Wajsbrot-Elgrabli, O., additional, Bougerol, T., additional, Fredembach, B., additional, Denoual, Q, additional, Bertrand, A., additional, Pouchon, A., additional, Bonny, G., additional, Brehon, L., additional, Durand, L., additional, Feuga, V., additional, Galliot, A.M., additional, Kayser, N., additional, Cussac, I., additional, Dupont, M.A., additional, Loftus, J., additional, Medecin, I., additional, Mazer, N., additional, Portalier, C., additional, Scognamiglio, C., additional, Bing, A., additional, Laurent, P., additional, Llorca, PM., additional, Samalin, L., additional, Foures, L., additional, Lacelle, D., additional, Pires, S., additional, Doriat, C., additional, Blanc, O., additional, Bennabi, D., additional, and Nicolier, M., additional

Published
2023
Full Text
View/download PDF

12. Incidence and predictors of metabolic syndrome onset in individuals with bipolar disorders: A longitudinal study from the FACE‐BD cohort.

Author

Godin, O., Olié, E., Fond, G., Aouizerate, B., Aubin, V., Bellivier, F., Belzeaux, R., Courtet, P., Dubertret, C., Haffen, E., Lefrere, A., Llorca, P. M., Polosan, M., Roux, P., Samalin, L., Schwan, R., Etain, B., Leboyer, M., Llorca, PM, and Barteau, V.

Subjects
BIPOLAR disorder, METABOLIC syndrome, ALCOHOLISM, SLEEP interruptions, LONGITUDINAL method
Abstract

Introduction: Metabolic syndrome (MetS) is a cluster of components including abdominal obesity, hyperglycemia, hypertension, and dyslipidemia. MetS is highly prevalent in individuals with bipolar disorders (BD) with an estimated global rate of 32.6%. Longitudinal data on incident MetS in BD are scarce and based on small sample size. The objectives of this study were to estimate the incidence of MetS in a large longitudinal cohort of 1521 individuals with BD and to identify clinical and biological predictors of incident MetS. Methods: Participants were recruited from the FondaMental Advanced Center of Expertise for Bipolar Disorder (FACE‐BD) cohort and followed‐up for 3 years. MetS was defined according to the International Diabetes Federation criteria. Individuals without MetS at baseline but with MetS during follow‐up were considered as having incident MetS. A logistic regression model was performed to estimate the adjusted odds ratio and its corresponding 95% confidence interval (CI) for an association between each factor and incident MetS during follow‐up. We applied inverse probability‐of‐censoring weighting method to minimize selection bias due to loss during follow‐up. Results: Among individuals without MetS at baseline (n = 1521), 19.3% developed MetS during follow‐up. Multivariable analyses showed that incident MetS during follow‐up was significantly associated with male sex (OR = 2.2, 95% CI = 1.7–3.0, p < 0.0001), older age (OR = 2.14, 95% CI = 1.40–3.25, p = 0.0004), presence of a mood recurrence during follow‐up (OR = 1.91, 95% CI = 1.22–3.00, p = 0.0049), prolonged exposure to second‐generation antipsychotics (OR = 1.56, 95% CI = 0.99, 2.45, p = 0.0534), smoking status at baseline (OR = 1.30, 95% CI = 1.00–1.68), lifetime alcohol use disorders (OR = 1.33, 95% CI = 0.98–1.79), and baseline sleep disturbances (OR = 1.04, 95% CI = 1.00–1.08), independently of the associations observed for baseline MetS components. Conclusion: We observed a high incidence of MetS during a 3 years follow‐up (19.3%) in individuals with BD. Identification of predictive factors should help the development of early interventions to prevent or treat early MetS. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Childhood trauma, dimensions of psychopathology and the clinical expression of bipolar disorders: A pathway analysis

Author

Henry, C., Etain, B., Leboyer, M., Laouamri, H., Souryis, K., Godin, O., Raust, A., Sportiche, S., Geoffroy, P.A., Aouizerate, B., Desage, A., Olie, E., Ducasse, D., Moliere, F., Belzeaux, R., Viglianaise, N., Lescalier, L., Job, S., Cohen, R., Wajsbrot-Elgrabli, O., Polosan, M., Garcon, S., Hardy-Bayle, M.C., Roux, P., Kayser, N., Grevin, I., Loftus, J., Albertini, L., Lajnef, M., Aubin, V., Azorin, J.M., Bellivier, F., Bougerol, T., Courtet, P., Gard, S., Kahn, J.P., and Passerieux, C.

Published
2017
Full Text
View/download PDF

16. Clinical and biological features associated to bipolar disorder with comorbid migraine: results from the FACE-BD cohort

Author

Patoz, M.-C., primary, Godin, O., additional, Moisset, X., additional, Chabert, J., additional, M’Bailara, K., additional, Etain, B., additional, Belzeaux, R., additional, Dubertret, C., additional, Haffen, E., additional, Schwan, R., additional, Roux, P., additional, Polosan, M., additional, Aubin, V., additional, Leboyer, M., additional, Courtet, P., additional, Olie, E., additional, Llorca, P.-M., additional, and Samalin, L., additional

Published
2023
Full Text
View/download PDF

17. Substance use disorders in bipolar patients with a painful expression

Author

Chabert, J., primary, Icick, R., additional, Cabé, J., additional, Patoz, M.-C., additional, Moisset, X., additional, Godin, O., additional, Gard, S., additional, Loftus, J., additional, Aubin, V., additional, Belzeaux, R., additional, Dubertret, C., additional, Lestrat, Y., additional, Mazer, N., additional, De Premorel, A., additional, Roux, P., additional, Polosan, M., additional, Schwitzer, T., additional, Aouizerate, B., additional, Isabelle, B., additional, Etain, B., additional, Moirand, R., additional, Olié, E., additional, Haffen, E., additional, Leboyer, M., additional, Courtet, P., additional, Llorca, P.-M., additional, Brousse, G., additional, and Samalin, L., additional

Published
2023
Full Text
View/download PDF

21. Outcomes for bipolar patients assessed in the French expert center network: A 2‐year follow‐up observational study (FondaMental Advanced Centers of Expertise for Bipolar Disorder [FACE‐BD])

Author

Henry, Chantal, Godin, Ophelia, Courtet, Philippe, Azorin, Jean‐Michel, Gard, Sébastien, Bellivier, Frank, Polosan, Mircea, Kahn, Jean‐Pierre, Roux, Paul, Aubin, Valerie, Costagliola, Dominique, Leboyer, Marion, Etain, Bruno, Laouamri, H, Souyris, K, Barteau, V, Geoffroy, PA, Raust, A, Belzeaux, R., Loftus, J, Sportiche, S, Aouizerate, B, Olié, E, Ducasse, D, Viglianese, N, Lescalier, L, Cohen, RF, Wajsbrot‐Elgrabli, O, Garçon, S, M’Bailara, Katia, Hardy‐Bayle, Marie‐Christine, and Grevin, I

Published
2017
Full Text
View/download PDF

22. Key findings on bipolar disorders from the longitudinal FondaMental Advanced Center of Expertise-Bipolar Disorder (FACE-BD) cohort

Author

Leboyer, M., primary, Godin, O., additional, Llorca, P.M., additional, Aubin, V., additional, Bellivier, F., additional, Belzeaux, R., additional, Courtet, P., additional, Costagliola, D., additional, Dubertret, C., additional, M'Bailara, K., additional, Haffen, E., additional, Henry, C., additional, Laouamri, H., additional, Passerieux, C., additional, Pelletier, A., additional, Polosan, M., additional, Roux, P., additional, Schwan, R., additional, Samalin, L., additional, Olié, E., additional, Etain, Bruno, additional, Etain, B., additional, Leboyer, M., additional, Barteau, V., additional, Bensalem, S., additional, Souryis, K., additional, Hotier, S., additional, Sanchez, J.P., additional, Saliou, E., additional, Hebbache, C., additional, Petrucci, J., additional, Wuillaume, L., additional, Bourdin, E., additional, Carminati, M., additional, Hennion, V., additional, Marlinge, E., additional, Meheust, J., additional, Zekri, C., additional, Desage, A., additional, Gard, S., additional, Minois, I., additional, Sportich, J., additional, Zanouy, L., additional, Abettan, C., additional, Bardin, L., additional, Cazals, A., additional, Deffinis, B., additional, Ducasse, D., additional, Gachet, M., additional, Henrion, A., additional, Martinerie, E., additional, Molière, F., additional, Noisette, B., additional, and Tarquini, E.G., additional

Published
2022
Full Text
View/download PDF

28. [French Expert advice on the management of valproate in childbearing and pregnant women with bipolar disorder]

Author

Samalin, L, Arnould, A, Boudieu, L, Henry, C, Haffen, E, Drapier, D, Anmella, G, Pacchiarotti, I, Vieta, E, Belzeaux, R, Llorca, P. M., Institut Pascal (IP), Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne (UCA)-Institut national polytechnique Clermont Auvergne (INP Clermont Auvergne), Université Clermont Auvergne (UCA)-Université Clermont Auvergne (UCA), CHU Clermont-Ferrand, GHU AP-HP Centre Université de Paris, Centre d'Investigation Clinique de Besançon (Inserm CIC 1431), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS BFC)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red Salud Mental [Madrid] (CIBER-SAM), Institut de Neurosciences de la Timone (INT), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Ce projet a reçu le support institutionnel de l’Association française de psychiatrie biologique et neuropsychopharmacologie.Les travaux de recherche du Dr Anmella sont soutenus par une bourse Rio Hortega 2021 (CM21/00017) financée par l'Instituto de Salud Carlos III (ISCIII) et cofinancée par le Fondo Social European Plus (FSE+).Les travaux de recherche du Dr Pacchiarotti sont soutenus par des bourses FIS 2018 et 2021 (PI18/01001, and PI21/00169) financées par l'Instituto de Salud Carlos III (ISCIII).

Subjects
Valproate, Bipolar Disorder, [SDV]Life Sciences [q-bio], Valproic Acid, Guidelines, Perinatal, Recommandations professionnelles, Childbearing, Pregnancy, Recurrence, Femme en âge de procréer, Périnatalité, Humans, Female, Anticonvulsants, Trouble bipolaire, Pregnant Women, Child, Antipsychotic Agents
Abstract

National audience; INTRODUCTION: The perinatal period is associated with high risk of relapses in women with untreated bipolar disorder (BD) and can have significant consequences on foetal and child development. Valproate is an effective mood stabilizer in BD but it is also the anticonvulsant associated to the highest risks of neurodevelopmental disorders and congenital malformations. The National Agency for the Safety of Medicines and Health Products (ANSM) changed the conditions of use and prescription of valproate in France in 2015. Its prescription is now contraindicated (i.e., not to be prescribed) in women able to have children unless alternative treatments are ineffective or not tolerated. Moreover, valproate could only be prescribed if the protocol of a specific pregnancy prevention program is followed. METHODS: A panel of experts from the French Association for Biological Psychiatry and Neuropsychopharmacology (AFPBN) provided consensus-based recommendations for switching and discontinuation of valproate in women with BD. The development of these recommendations consisted of an adaptation to French clinical practice based on a European expert opinion published in 2019. The experts discussed five real-world clinical situations in light of the scientific evidence and their clinical experience (a. Stable BD patient with valproate monotherapy who is planning pregnancy, b. Stable BD patient with valproate polytherapy who is planning pregnancy, c. Unstable BD patient with frequent relapses and valproate polytherapy who is planning pregnancy, d. Stable BD patient treated with valproate and unexpected pregnancy, e. Unstable BD patient treated with valproate and unexpected pregnancy) and developed, through several rounds of exchange drafts, a French version of clinical recommendations. RESULTS: First of all, some factors need to be considered for establishing personalized practical recommendations for a safe and effective switching or discontinuation of valproate in any clinical situations: planned pregnancy or unplanned pregnancy or current pregnancy, the existence or not of a pregnancy risk minimization program and a complete treatment history. Other factors that should be considered are the predominant polarity, the severity, the stability, the comorbidities associated with BD, the beliefs toward treatments, the family situation and the preference of the patient. The modalities for switching or discontinuation of valproate in women with BD were related to the clinical situation. First-line therapeutic alternatives such as lithium, lamotrigine, quetiapine, olanzapine or aripiprazole were preferred for patients suffering from a clinically stable BD considering pregnancy or pregnant. In patients suffering from clinically unstable BD, to reach stability was considered first. A shared decision-making should be systematically implemented and the patient must be fully informed of the risks related to an in-utero exposure to valproate, and the risks of the discontinuation/switch that is considered. CONCLUSION: Although the adaptation to French practice of the recommendations from the European expert opinion highlighted some differences in the criteria taken into consideration to guide the therapeutic decision, this expert advice will guide the clinician for switching and discontinuation of valproate in BD women able to have children or pregnant.

Published
2022

29. Predictors of Functional Impairment in Bipolar Disorder: Results from 13 Cohorts from Seven Countries by The Global Bipolar Cohort Collaborative

Author

Burdick, KE, Millett, CE, Yocum, AK, Altimus, CM, Andreassen, OA, Aubin, V, Belzeaux, R, Berk, Michael, Biernacka, JM, Blumberg, HP, Cleare, AJ, Diaz‐Byrd, C, Dubertret, C, Etain, B, Eyler, L, Forester, BP, Fullerton, JM, Frye, MA, Gard, S, Godin, O, Haffen, E, Klaus, F, Lagerberg, TV, Leboyer, M, Martinez‐Aran, A, McElroy, S, Mitchell, PB, Olie, E, Olorunfemi, P, Passerieux, C, Peters, A, Pham, DL, Polosan, M, Potter, JR, Sajatovic, M, Samalin, L, Schwan, R, Shanahan, M, Solé, B, Strawbridge, R, Stuart, Amanda, Torres, I, Ueland, T, Vieta, E, Williams, Lana, Wrobel, Anna, Yatham, LN, Young, AH, Nierenberg, A, McInnis, MG, Burdick, KE, Millett, CE, Yocum, AK, Altimus, CM, Andreassen, OA, Aubin, V, Belzeaux, R, Berk, Michael, Biernacka, JM, Blumberg, HP, Cleare, AJ, Diaz‐Byrd, C, Dubertret, C, Etain, B, Eyler, L, Forester, BP, Fullerton, JM, Frye, MA, Gard, S, Godin, O, Haffen, E, Klaus, F, Lagerberg, TV, Leboyer, M, Martinez‐Aran, A, McElroy, S, Mitchell, PB, Olie, E, Olorunfemi, P, Passerieux, C, Peters, A, Pham, DL, Polosan, M, Potter, JR, Sajatovic, M, Samalin, L, Schwan, R, Shanahan, M, Solé, B, Strawbridge, R, Stuart, Amanda, Torres, I, Ueland, T, Vieta, E, Williams, Lana, Wrobel, Anna, Yatham, LN, Young, AH, Nierenberg, A, and McInnis, MG

Published
2022

30. Influence of childhood maltreatment on prevalence, onset and persistence of psychiatric comorbidities and suicide attempts in bipolar disorders

Author

Grillault Laroche, D., Godin, O., Dansou, Y., Belzeaux, R., Aouizerate, B., Burté, T., Courtet, Philippe, Dubertret, C., Haffen, E., Llorca, P.M., Olié, Émilie, Roux, P., Polosan, M., Schwan, R., Leboyer, M., Bellivier, F., Marie-Claire, C., Etain, B., Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Optimisation thérapeutique en Neuropsychopharmacologie (OPTeN (UMR_S_1144 / U1144)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), CHU Henri Mondor [Créteil], Fondation FondaMental [Créteil], Assistance Publique - Hôpitaux de Marseille (APHM), Institut de Neurosciences de la Timone (INT), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Centre hospitalier Charles Perrens [Bordeaux], Nutrition et Neurobiologie intégrée (NutriNeuro), Université de Bordeaux (UB)-Institut Polytechnique de Bordeaux-Ecole nationale supérieure de chimie, biologie et physique-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Princesse Grace, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Génomique Fonctionnelle (IGF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Université Paris Cité (UPCité), Hôpital Louis Mourier - AP-HP [Colombes], Institut de psychiatrie et neurosciences de Paris (IPNP - U1266 Inserm), Centre d'Investigation Clinique de Besançon (Inserm CIC 1431), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS BFC)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), CHU Clermont-Ferrand, Université Clermont Auvergne (UCA), Centre Hospitalier de Versailles André Mignot (CHV), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, [GIN] Grenoble Institut des Neurosciences (GIN), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes (UGA), Université de Lorraine (UL), Centre Psychothérapique de Nancy [Laxou] (CPN), ANR-11-IDEX-0004,SUPER,Sorbonne Universités à Paris pour l'Enseignement et la Recherche(2011), ANR-10-COHO-0010,Psy-COH,FondaMental-Cohortes(2010), Neurobiologie des interactions cellulaires et neurophysiopathologie - NICN (NICN), Centre National de la Recherche Scientifique (CNRS)-Université de la Méditerranée - Aix-Marseille 2, AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, Inserm U1266, 178, rue des Renouillers, 92700 Colombes, France, UFR de Médecine Paris Nord, Université de Paris, 16, rue Henri Huchard, 75018 Paris, France., Groupe de Recherche en Psychologie Sociale (GRePS), Université Lumière - Lyon 2 (UL2), Praticien Hospitalier Universitaire, CPN Laxou, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPC), Guerineau, Nathalie C., Sorbonne Universités à Paris pour l'Enseignement et la Recherche - - SUPER2011 - ANR-11-IDEX-0004 - IDEX - VALID, Cohortes - FondaMental-Cohortes - - Psy-COH2010 - ANR-10-COHO-0010 - COHO - VALID, CHU Henri Mondor, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])-Université de Franche-Comté (UFC), and Hôpital Charles Perrens

Subjects
bipolar disorder, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, childhood trauma, [SDV]Life Sciences [q-bio], childhood maltreatment, prevalence, substance use, Suicide, Attempted, sequence, anxiety, comorbidities, Suicidal Ideation, [SDV] Life Sciences [q-bio], Psychiatry and Mental health, [SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, mental disorders, Humans, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Child Abuse, Child, network analysis, suicide, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

BackgroundPsychiatric comorbidities and suicide attempts are highly prevalent in Bipolar Disorders (BD). We examined the associations between childhood maltreatment, psychiatric comorbidities, and suicide attempts, in terms of lifetime prevalence, sequence of onset, and current symptoms.MethodsWe assessed 3,047 individuals with BD for suicide attempts, anxiety disorders, substance use disorders, and eating disorders. Participants completed a self-report for the assessment of childhood maltreatment. Associations between childhood maltreatment and characteristics of comorbidities (lifetime prevalence, current symptoms, and age at onset) were examined using logistic regressions and network analyses.ResultsPsychiatric comorbidities were frequent with a mean number per individual of 1.23 (SD = 1.4). Most comorbidities occurred prior to the onset of BD. Participants who reported higher levels of childhood maltreatment had more frequent and multiple comorbidities, which were also more currently active at inclusion. Childhood maltreatment did not decrease the age of onset of comorbidities, but was associated with a faster accumulation of comorbidities prior to the onset of BD. Logistic regression and network analyses showed that emotional abuse and sexual abuse might play a prominent role in the lifetime prevalence of psychiatric comorbidities and suicide attempts.ConclusionsChildhood maltreatment was associated with suicide attempts, and with frequent, multiple, and persistent psychiatric comorbidities that accumulated more rapidly prior to the onset of BD. Hence, childhood maltreatment should be systematically assessed in individuals with BD, in particular when the course of the disorder is characterized by a high comorbid profile or by a high suicidality.

Published
2022

32. Childhood maltreatment and metabolic syndrome in bipolar disorders: In search of moderators

Author

Etain, B., Henry, C., Olié, E., Leboyer, M., Haffen, E., Llorca, PM, Barteau, V., Bensalem, S., Godin, O., Laouamri, H., Souryis, K., Hotier, S., Pelletier, A., Drancourt, N., Sanchez, JP., Saliou, E., Hebbache, C., Petrucci, J., Willaume, L., Bourdin, E., Bellivier, F., Carminati, M., Marlinge, E., Meheust, J., Meyrel, M., Aouizerate, B., Desage, A., Gard, S., Sportich, J, Mbailara, K., Minois, I., Zanouy, L., Bardin, L., Cazals, A., Courtet, P., Deffinis, B., Ducasse, D., Gachet, M., Henrion, A., Moliere, F., Noisette, B., Olie, E., Tarquini, G., Belzeaux, R., Correard, N., Groppi, F., Lefrere, A., Lescalier, L., Moreau, E., Pastol, J., Rebattu, M., Roux, B., Viglianese, N., Cohen, R., Schwan, Raymond, Kahn, J.P., Milazzo, M., Wajsbrot-Elgrabli, O., Bougerol, T., Fredembach, B., Suisse, A., Halili, B., Pouchon, A, Polosan, M., Galliot, A.M., Grévin, I., Cannavo, A.S., Kayser, N., Passerieux, C., Roux, P., Service de Psychiatrie, Aubin, V., Cussac, I., Dupont, M.A, Loftus, J., Medecin, I., Dubertret, C., Mazer, N., Portalier, C., Scognamiglio, C., Bing, A., Godin, Ophelia, Gaube, Géraud, Olié, Emilie, Belzeaux, Raoul, Bellivier, Frank, Loftus, Joséphine, Courtet, Philippe, Dubertret, Caroline, llorca, Pierre-Michel, Gard, Sebastien, Henry, Chantal, Schwan, Raymund, Passerieux, Christine, Polosan, Mircea, Samalin, Ludovic, Leboyer, Marion, and Etain, Bruno

Published
2021
Full Text
View/download PDF

36. Clinical characteristics of bipolar disorders with postpartum depressive onset

Author

Tebeka, Sarah, primary, Godin, Ophelia, additional, Mazer, Nicolas, additional, Bellivier, Frank, additional, Courtet, Philippe, additional, Etain, Bruno, additional, Gard, Sébastien, additional, Leboyer, Marion, additional, Llorca, Pierre-Michel, additional, Loftus, Joséphine, additional, Olié, Emilie, additional, Passerieux, Christine, additional, Polosan, Mircea, additional, Schwan, Raymund, additional, Belzeaux, Raoul, additional, Dubertret, Caroline, additional, Etain, B., additional, Henry, C., additional, Olié, E., additional, Leboyer, M., additional, Haffen, E., additional, Llorca, P.M., additional, Barteau, V., additional, Bensalem, S., additional, Godin, O., additional, Laouamri, H., additional, Souryis, K., additional, Hotier, S., additional, Pelletier, A., additional, Drancourt, N., additional, Sanchez, J.P., additional, Saliou, E., additional, Hebbache, C., additional, Petrucci, J., additional, Willaume, L., additional, Bourdin, E., additional, Bellivier, F., additional, Carminati, M., additional, Marlinge, E., additional, Meheust, J., additional, Antoniol, B., additional, Desage, A., additional, Gard, S., additional, Jutant, A., additional, Mbailara, K., additional, Minois, I., additional, Zanouy, L., additional, Abettan, C., additional, Bardin, L., additional, Cazals, A., additional, Courtet, P., additional, Deffinis, B., additional, Ducasse, D., additional, Gachet, M., additional, Henrion, A., additional, Martinerie, E., additional, Molière, F., additional, Noisette, B., additional, Tarquini, G., additional, Azorin, J.M., additional, Belzeaux, R., additional, Correard, N., additional, Consoloni, J.L., additional, Groppi, F., additional, Lescalier, L., additional, Montant, J., additional, Rebattu, M., additional, Viglianese, N., additional, Cohen, R., additional, Kahn, J.P., additional, Milazzo, M., additional, Wajsbrot-Elgrabli, O., additional, Bougerol, T., additional, Fredembach, B., additional, Suisse, A., additional, Halili, B., additional, Pouchon, A., additional, Polosan, M., additional, Galliot, A.M., additional, Grévin, I., additional, Cannavo, A.S., additional, Kayser, N., additional, Passerieux, C., additional, Roux, P., additional, Aubin, V., additional, Cussac, I., additional, Dupont, M.A., additional, Loftus, J., additional, Medecin, I., additional, Dubertret, C., additional, Mazer, N., additional, Portalier, C., additional, Scognamiglio, C., additional, and Bing, A., additional

Published
2021
Full Text
View/download PDF

37. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion

Author

Cleynen, I., Engchuan, W., Hestand, M. S., Heung, T., Holleman, A. M., Johnston, H. R., Monfeuga, T., McDonald-McGinn, D. M., Gur, R. E., Morrow, B. E., Swillen, A., Vorstman, J. A. S., Bearden, C. E., Chow, E. W. C., van den Bree, M., Emanuel, B. S., Vermeesch, J. R., Warren, S. T., Owen, M. J., Chopra, P., Cutler, D. J., Duncan, R., Kotlar, A. V., Mulle, J. G., Voss, A. J., Zwick, M. E., Diacou, A., Golden, A., Guo, T., Lin, J. -R., Wang, T., Zhang, Z., Zhao, Yu Yang, Marshall, C., Merico, D., Jin, A., Lilley, B., Salmons, H. I., Tran, O., Holmans, P., Pardinas, A., Walters, J. T. R., Demaerel, W., Boot, E., Butcher, N. J., Costain, G. A., Lowther, C., Evers, R., van Amelsvoort, T. A. M. J., van Duin, E., Vingerhoets, C., Breckpot, J., Devriendt, K., Vergaelen, E., Vogels, A., Crowley, T. B., Mcginn, D. E., Moss, E. M., Sharkus, R. J., Unolt, M., Zackai, E. H., Calkins, M. E., Gallagher, R. S., Gur, R. C., Tang, S. X., Fritsch, R., Ornstein, C., Repetto, G. M., Breetvelt, E., Duijff, S. N., Fiksinski, A., Moss, H., Niarchou, M., Murphy, K. C., Prasad, S. E., Daly, E. M., Gudbrandsen, M., Murphy, C. M., Murphy, D. G., Buzzanca, A., Fabio, F. D., Digilio, M. C., Pontillo, M., Marino, B., Vicari, Stefano, Coleman, K., Cubells, J. F., Ousley, O. Y., Carmel, M., Gothelf, D., Mekori-Domachevsky, E., Michaelovsky, E., Weinberger, R., Weizman, A., Kushan, L., Jalbrzikowski, M., Armando, M., Eliez, S., Sandini, C., Schneider, M., Bena, F. S., Antshel, K. M., Fremont, W., Kates, W. R., Belzeaux, R., Busa, T., Philip, N., Campbell, L. E., Mccabe, K. L., Hooper, S. R., Schoch, K., Shashi, V., Simon, T. J., Tassone, F., Arango, C., Fraguas, D., Garcia-Minaur, S., Morey-Canyelles, J., Rosell, J., Suner, D. H., Raventos-Simic, J., Epstein, M. P., Williams, N. M., Bassett, A. S., Zhao Y., Vicari S. (ORCID:0000-0002-5395-2262), Cleynen, I., Engchuan, W., Hestand, M. S., Heung, T., Holleman, A. M., Johnston, H. R., Monfeuga, T., McDonald-McGinn, D. M., Gur, R. E., Morrow, B. E., Swillen, A., Vorstman, J. A. S., Bearden, C. E., Chow, E. W. C., van den Bree, M., Emanuel, B. S., Vermeesch, J. R., Warren, S. T., Owen, M. J., Chopra, P., Cutler, D. J., Duncan, R., Kotlar, A. V., Mulle, J. G., Voss, A. J., Zwick, M. E., Diacou, A., Golden, A., Guo, T., Lin, J. -R., Wang, T., Zhang, Z., Zhao, Yu Yang, Marshall, C., Merico, D., Jin, A., Lilley, B., Salmons, H. I., Tran, O., Holmans, P., Pardinas, A., Walters, J. T. R., Demaerel, W., Boot, E., Butcher, N. J., Costain, G. A., Lowther, C., Evers, R., van Amelsvoort, T. A. M. J., van Duin, E., Vingerhoets, C., Breckpot, J., Devriendt, K., Vergaelen, E., Vogels, A., Crowley, T. B., Mcginn, D. E., Moss, E. M., Sharkus, R. J., Unolt, M., Zackai, E. H., Calkins, M. E., Gallagher, R. S., Gur, R. C., Tang, S. X., Fritsch, R., Ornstein, C., Repetto, G. M., Breetvelt, E., Duijff, S. N., Fiksinski, A., Moss, H., Niarchou, M., Murphy, K. C., Prasad, S. E., Daly, E. M., Gudbrandsen, M., Murphy, C. M., Murphy, D. G., Buzzanca, A., Fabio, F. D., Digilio, M. C., Pontillo, M., Marino, B., Vicari, Stefano, Coleman, K., Cubells, J. F., Ousley, O. Y., Carmel, M., Gothelf, D., Mekori-Domachevsky, E., Michaelovsky, E., Weinberger, R., Weizman, A., Kushan, L., Jalbrzikowski, M., Armando, M., Eliez, S., Sandini, C., Schneider, M., Bena, F. S., Antshel, K. M., Fremont, W., Kates, W. R., Belzeaux, R., Busa, T., Philip, N., Campbell, L. E., Mccabe, K. L., Hooper, S. R., Schoch, K., Shashi, V., Simon, T. J., Tassone, F., Arango, C., Fraguas, D., Garcia-Minaur, S., Morey-Canyelles, J., Rosell, J., Suner, D. H., Raventos-Simic, J., Epstein, M. P., Williams, N. M., Bassett, A. S., Zhao Y., and Vicari S. (ORCID:0000-0002-5395-2262)

Abstract

Schizophrenia occurs in about one in four individuals with 22q11.2 deletion syndrome (22q11.2DS). The aim of this International Brain and Behavior 22q11.2DS Consortium (IBBC) study was to identify genetic factors that contribute to schizophrenia, in addition to the ~20-fold increased risk conveyed by the 22q11.2 deletion. Using whole-genome sequencing data from 519 unrelated individuals with 22q11.2DS, we conducted genome-wide comparisons of common and rare variants between those with schizophrenia and those with no psychotic disorder at age ≥25 years. Available microarray data enabled direct comparison of polygenic risk for schizophrenia between 22q11.2DS and independent population samples with no 22q11.2 deletion, with and without schizophrenia (total n = 35,182). Polygenic risk for schizophrenia within 22q11.2DS was significantly greater for those with schizophrenia (padj = 6.73 × 10−6). Novel reciprocal case–control comparisons between the 22q11.2DS and population-based cohorts showed that polygenic risk score was significantly greater in individuals with psychotic illness, regardless of the presence of the 22q11.2 deletion. Within the 22q11.2DS cohort, results of gene-set analyses showed some support for rare variants affecting synaptic genes. No common or rare variants within the 22q11.2 deletion region were significantly associated with schizophrenia. These findings suggest that in addition to the deletion conferring a greatly increased risk to schizophrenia, the risk is higher when the 22q11.2 deletion and common polygenic risk factors that contribute to schizophrenia in the general population are both present.

Published
2020

38. Trajectories of functioning in bipolar disorders: A longitudinal study in the FondaMental Advanced Centers of Expertise in Bipolar Disorders cohort

Author

Godin, Ophelia, primary, Leboyer, Marion, additional, Mazroui, Yassin, additional, Aouizerate, Bruno, additional, Azorin, Jean-Michel, additional, Raoul, Belzeaux, additional, Bellivier, Frank, additional, Polosan, Mircea, additional, Courtet, Philippe, additional, Dubertret, Caroline, additional, Henry, Chantal, additional, Kahn, Jean-Pierre, additional, Loftus, Josephine, additional, Olié, Emilie, additional, Passerieux, Christine, additional, Costagliola, Dominique, additional, Etain, Bruno, additional, Haffen, E., additional, Llorca, P.M., additional, Barteau, V., additional, Bensalem, S., additional, Laaidi, M., additional, Laouamri, H., additional, Souryis, K., additional, Hotier, S., additional, Pelletier, A., additional, Drancourt, N., additional, Sanchez, J.P., additional, Saliou, E., additional, Hebbache, C., additional, Petrucci, J., additional, Willaume, L., additional, Bourdin, E., additional, Carminati, M., additional, Etain, B., additional, Marlinge, E., additional, Meheust, J., additional, Antoniol, B., additional, Desage, A., additional, Gard, S., additional, Jutant, A., additional, Mbailara, K., additional, Minois, I., additional, Zanouy, L., additional, Abettan, C., additional, Bardin, L., additional, Cazals, A., additional, Deffinis, B., additional, Ducasse, D., additional, Gachet, M., additional, Henrion, A., additional, Martinerie, E., additional, Molière, F., additional, Noisette, B., additional, Tarquini, G., additional, Belzeaux, R., additional, Correard, N., additional, Consoloni, J. L., additional, Groppi, F., additional, Lescalier, L., additional, Montant, J., additional, Rebattu, M., additional, Viglianese, N., additional, Cohen, R., additional, Milazzo, M., additional, Wajsbrot-Elgrabli, O., additional, Bougerol, T., additional, Fredembach, B., additional, Garçon, S., additional, Grignon, P., additional, Perrin, A., additional, Galliot, A.M., additional, Grévin, I., additional, Cannavo, A.S., additional, Kayser, N., additional, Roux, P., additional, Aubin, V., additional, Cussac, I., additional, Dupont, M.A., additional, Medecin, I., additional, Mazer, N., additional, and Portalier, C., additional

Published
2020
Full Text
View/download PDF

43. Trajectoire du trouble bipolaire en fonction de sa séquence d’installation avec les troubles liés à l’usage d’alcool dans la cohorte des centres experts du réseau fondamental : identifier des cibles thérapeutiques

Author

Aubin, V., primary, Belzeaux, R., additional, Biseul, I., additional, Brousse, G., additional, Gard, S., additional, Godin, O., additional, Guillaume, S., additional, Icick, R., additional, Loftus, J., additional, and Samalin, L., additional

Published
2019
Full Text
View/download PDF

44. Essai randomisé contrôlé évaluant l’efficacité d’un serious game pour maintenir la qualité de l’adhésion médicamenteuse dans les suites d’un programme de psychoéducation dans le cadre du trouble bipolaire

Author

Dupuis Maurin, K., primary, Girod, C., additional, Consolini, J.L., additional, Belzeaux, R., additional, Etain, B., additional, Cochet, B., additional, Leboyer, M., additional, Genty, C., additional, Gamon, C., additional, Picot, M.C., additional, Courtet, P., additional, and Olié, E., additional

Published
2019
Full Text
View/download PDF

45. Affect lability predicts occurrence of suicidal ideation in bipolar patients: a two-year prospective study

Author

Ducasse, D., Jaussent, I., Guillaume, S., Azorin, J., Bellivier, F., Belzeaux, R., Bougerol, T., Etain, B., Gard, S., Henry, C., Kahn, J.P., Leboyer, M., Loftus, J., Passerieux, C., Collaborators, FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD), Olié, E., Courtet, P., Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Neuropsychiatrie : recherche épidémiologique et clinique (PSNREC), Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Fondation FondaMental [Créteil], Département Universitaire de Psychiatrie - [Hôpital Sainte Marguerite - APHM] (Hôpitaux Sud), Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud )-Assistance Publique - Hôpitaux de Marseille (APHM)-Aix Marseille Université (AMU), Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Grenoble, Pôle de Psychiatrie [Hôpital Henri Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital H. Mondor - A. Chenevier, Hôpital Charles Perrens, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Hôpital Princesse Grace [Monaco], Centre Hospitalier de Versailles André Mignot (CHV), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Centre hospitalier Charles Perrens [Bordeaux], Herrada, Anthony, and Université Montpellier 1 (UM1)-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Adult, Male, medicine.medical_specialty, media_common.quotation_subject, [SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, Suicide, Attempted, Anger, Affect (psychology), 03 medical and health sciences, 0302 clinical medicine, Risk Factors, medicine, Humans, Prospective Studies, Bipolar disorder, Prospective cohort study, Psychiatry, Suicidal ideation, Depression (differential diagnoses), Aged, media_common, Psychiatric Status Rating Scales, prospective follow-up study, bipolar disorder, Lability, business.industry, Incidence, Middle Aged, medicine.disease, 030227 psychiatry, 3. Good health, suicidal ideation, Psychiatry and Mental health, affect lability, [SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, Female, medicine.symptom, business, 030217 neurology & neurosurgery, Anxiety disorder, Follow-Up Studies, Clinical psychology
Abstract

International audience; Objective: The aim of our study was to investigate, in bipolar patients, whether affect lability was associated with suicidal ideation incidence during 2-year follow-up, and which subtype of affect lability was associated with suicidal ideation.Method: A total of 319 euthymic or mildly depressed bipolar outpatients recruited in the French FondaMental Advanced Centres of Expertise for Bipolar Disorder were divided into two subgroups according to the occurrence of suicidal ideation during a 2-year follow-up. Affect lability was assessed by the French version of the Affect Lability Scale.Results: Bipolar patients with high affect lability were more likely to report suicidal ideation during follow-up, even after adjustment for age, study level, rapid cycling, current depression level, anxiety disorder, and lifetime history SA (OR = 2.47; 95% CI [1.15-5.30], P = 0.01). The risk of suicidal ideation increased with the level of affect lability. More specifically, the propensity to switch from neutral to elation affect, from anxious to depressive affect (or inversely), and from neutral to anger affect predicted suicidal ideation.Conclusion: Reducing affective lability could become a new therapeutic target of suicidal prevention in bipolar disorder.

Published
2017

47. Conclusions

Author

Adida, M., primary, Belzeaux, R., additional, Fakra, E., additional, and Kaladjian, A., additional

Published
2018
Full Text
View/download PDF

48. Childhood trauma, dimensions of psychopathology and the clinical expression of bipolar disorders: A pathway analysis

Author

Etain, B., primary, Lajnef, M., additional, Henry, C., additional, Aubin, V., additional, Azorin, J.M., additional, Bellivier, F., additional, Bougerol, T., additional, Courtet, P., additional, Gard, S., additional, Kahn, J.P., additional, Passerieux, C., additional, Leboyer, M., additional, Etain, B., additional, Laouamri, H., additional, Souryis, K., additional, Godin, O., additional, Raust, A., additional, Sportiche, S., additional, Geoffroy, P.A., additional, Aouizerate, B., additional, Desage, A., additional, Olie, E., additional, Ducasse, D., additional, Moliere, F., additional, Belzeaux, R., additional, Viglianaise, N., additional, Lescalier, L., additional, Job, S., additional, Cohen, R., additional, Wajsbrot-Elgrabli, O., additional, Polosan, M., additional, Garcon, S., additional, Hardy-Bayle, M.C., additional, Roux, P., additional, Kayser, N., additional, Grevin, I., additional, Loftus, J., additional, and Albertini, L., additional

Published
2017
Full Text
View/download PDF

49. Hallucinations Toward a Dialogue between Phenomenology and Brain Imaging Research?

Author

Belzeaux, R., Cermolacce, M., Renaud Jardri, Centre de recherche en neurobiologie - neurophysiologie de Marseille (CRN2M), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Neurosciences Cognitives [Marseille] (LNC), Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Département Universitaire de Psychiatrie - [Hôpital Sainte Marguerite - APHM] (Hôpitaux Sud), Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud )-Assistance Publique - Hôpitaux de Marseille (APHM)-Aix Marseille Université (AMU), Pôle de Psychiatrie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud )-CHU Marseille, Sciences Cognitives et Sciences Affectives (SCALab) - UMR 9193 (SCALab), Université de Lille-Centre National de la Recherche Scientifique (CNRS), Hôpital Fontan (CHRU Lille), Group for Neural Theory [Paris], Laboratoire de Neurosciences Cognitives & Computationnelles (LNC2), Département d'Etudes Cognitives - ENS Paris (DEC), École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Département d'Etudes Cognitives - ENS Paris (DEC), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Labex Institut d'étude de la cognition (IEC), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 (SCALab), École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-École normale supérieure - Paris (ENS-PSL), and Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud )

Subjects
[SCCO]Cognitive science, [SCCO.NEUR]Cognitive science/Neuroscience, ComputingMilieux_MISCELLANEOUS
Abstract

Hallucinations refer to a wide range of subjective human experiences. As a consequence, hallucinations constitute fascinating phenomena for the dialogue between phenomenology and neuroscience. We propose a summary of the possible strategies of this dialogue encompassing neurophenomenology or front-loaded phenomenology. We question the issue of the continuity of hallucinatory experiences, at both the subjective (phenomenology) and objective (brain imaging) levels. We also question the possible links between hallucinations and self-disorders, and discuss how these connections may add value to the understanding of hallucinations at both levels of interest. As only a very limited amount of experimental work has specifically focused on hallucinations based on this dialogue between phenomenology and brain imaging, we conclude by describing potential starting points for future studies.

Published
2016

50. Symptômes négatifs dans la schizophrénie et addiction Negative symptoms in schizophrenia and substance-related disorders

Author

Simon, N, Belzeaux, R, Adida, M, Azorin, J.-M, Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U912 INSERM - Aix Marseille Univ - IRD), Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Centre antipoison et de toxicovigilance (Marseille) (CAPTV Marseille), Assistance Publique - Hôpitaux de Marseille (APHM), Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Malbec, Odile

Subjects
[SDV] Life Sciences [q-bio], [SDV]Life Sciences [q-bio], Schizophrenia, Addiction, Negative symptoms, Schizophrénie, Alcohol, Symptômes négatifs, Alcool
Abstract

International audience; Dual diagnosis of schizophrenia and substance-related disorders is common in psychiatric practice. Epidemiologic studies and report have established that the risk of a substance-related disorder was 4 to 5 times higher in a population of psychiatric patients than in the general population. However, little is known on the reason of this relationship and the treatments required. It's well known that a family history of psychosis is a risk factor of schizophrenia. Similarly a family history of substance use disorders increases the risk of using substances. Because the two disorders often occurred together, it could be hypothesized that a genetic risk factor is common. However, recent studies did not confirm this hypothesis and it seems that their genetic risks factor would be unrelated. Evidence now exists describing the different profiles of patients whether they used substance or not. Concerning negative symptoms clinical studies and meta-analyses have described fewer symptoms in schizophrenia patients with a substance use disorder. Among the different explanations that have been addressed, it seems that a lower capability of obtaining the substance could partly explain this relationship. Perhaps because patients with social withdrawal have more difficulties to find and spend the time required to obtain abused substances. At the opposite some products such as cocaine may relieve some symptoms especially anhedonia and alogia. However the link between substance-related disorders and negative symptoms is weak and decreases in more recent studies, probably because negative symptoms as well as addiction disorders are better characterized. Considering that treating psychiatric symptoms may not always lead to a decrease in the substance-related disorders but that patients who give up substances improve their psychotic symptoms, a therapeutic strategy should be planned for these dual disorders patients combining psychiatry and addiction interventions.

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results